bpc 157 clinical trial nct BPC-157 Research Peptide | Batch Documentation bovinos

Wolverine Peptide Stack: BPC-157 + TB-500 Therapy | OFH

Here are examples of what you need: - The full name of the patient - The full names and credentials of the professionals handling the patient - The name, address, and facility type of the place where the injection was administered - The relevant information and indications concerning the patient's condition/disease in their medical records to justify medical necessity - Drug information (e.g., name, strength, dose, total dose administered, manufacturer, lot number, National Drug Code, expiration date, etc.) - Signed provider order with information about the frequency and route - Any relevant tests (e.g., blood tests, imaging tests showing tumor locations and size) - Documentation of patient monitoring and responses (e.g., lab results, treatment progression, remission status) ## **Billing requirements J9041** Besides the documentation requirements above, please take note of or have the following: - 0.1 mg = 1 unit - Indicate the relevant ICD code applicable to your patient's condition - Indicate the relevant CPT codes applicable to the patient's treatment (e.g., CPT code 96401, 96409, etc.) - Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication

bovinos

Size:1000 mcg/ml - 10 ml (Pack of 5)

Analysis was performed as previously described, using a Dionex Integrion ion chromatography system (Thermo Fisher Scientific)